Cazzaniga, Marina Elena <br/><br/>
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies.  [electronic resource] 

 -  Breast care (Basel, Switzerland)  Feb 2020 
 - 30-37 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1661-3791 
<br/><br/><label>Standard No.: </label>10.1159/000495469  doi